| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1639325-43-1 | Givosiran | Csub78/subHsub13/subsub9/subNsub11/subOsub30/sub |
| 1639351-92-0 | Mc-Val-Cit-PAB-Cl | Csub28/subHsub39/subClNsub6/subOsub6/sub |
| 1639454-74-2 | trans-2-((tert-Butoxycarbonyl)amino)-1-fluorocyclobutane-1-carboxylicacid | Csub10/subHsub16/subFNOsub4/sub |
| 1639454-84-4 | (1R,2R)-2-{[(tert-butoxy)carbonyl]amino}-1-fluorocyclobutane-1-carboxylic acid | Csub10/subHsub16/subFNOsub4/sub |
| 1639866-72-0 | 3-Amino-5-ethynylbenzoic acid | Csub9/subHsub7/subNOsub2/sub |
| 1639970-62-9 | Sacubitril Impurity 57 | Csub22/subHsub23/subNOsub4/sub |
| 1640282-31-0 | 1-[7-(3,4-Dimethoxyphenyl)-2,3-dihydro-9-[[(3S)-1-methyl-3-piperidinyl]methoxy]-1,4-benzoxazepin-4(5H)-yl]-1-propanone | Csub27/subHsub36/subNsub2/subOsub5/sub |
| 1640292-55-2 | trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide (2Z)-2-butenedioate (1:1) | Csub15/subHsub23/subNsub5/subOsub2/subS.Csub4/subHsub4/subOsub4/sub |
| 1640971-87-4 | Tofacitinib Related Compound 2 HCl | Csub10/subHsub18/subClNsub3/subO |
| 1640972-35-5 | Tofacitinib Impurity | Csub16/subHsub22/subNsub6/subO |
| 1640981-19-6 | 4-Hydroxy-2-methyl-1-(phenylmethyl)-1H-benzimidazole-6-carboxylic acid | Csub16/subHsub14/subNsub2/subOsub3/sub |
| 1642288-47-8 | Mavacamten | Csub15/subHsub19/subNsub3/subOsub2/sub |
| 1642298-59-6 | 3-(Fluoromethyl)azetidine hydrochloride | Csub4/subHsub9/subClFN |
| 1642303-38-5 | Lenrispodun phosphate | Csub29/subHsub29/subFNsub7/subOsub5/subP |
| 1642306-14-6 | Otophylloside T | Csub48/subHsub70/subOsub18/sub |
| 1642308-34-6 | 2,6-Bis[4-(9H-carbazol-9-yl)phenyl]-9,10-anthracenedione | Csub50/subHsub30/subNsub2/subOsub2/sub |
| 1642330-72-0 | 2-(Biphenyl-4-yl)-4-(4-chlorophenyl)-6-phenyl-1,3,5-triazine | Csub27/subHsub18/subClNsub3/sub |
| 1642330-94-6 | Rosuvastatin Impurity 41 | Csub15/subHsub26/subOsub6/sub |
| 1642542-05-9 | 1-Bromo-5-chloro-3-fluoro-2-nitrobenzene | Csub6/subHsub2/subBrClFNOsub2/sub |
| 1642571-08-1 | tert-Butyl (S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate | Csub27/subHsub30/subNsub6/subOsub3/sub |
| 1642630-12-3 | 3-(4-Phenoxyphenyl)-1-(3S)-3-piperidinyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Csub22/subHsub22/subNsub6/subO |
| 1642853-67-5 | N-[(2,3-Dihydro-1-methyl-2-oxo-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | Csub19/subHsub20/subNsub4/subOsub4/sub |
| 1642873-03-7 | N-Propylsulfamide sodium salt | Csub3/subHsub9/subNsub2/subOsub2/subSNa |
| 1643141-20-1 | 1-Methyl-3-[(methylamino)methyl]-1H-pyrazole-5-carbonitrile hydrochloride (1:1) | Csub7/subHsub10/subNsub4/sub.HCl |
| 1643156-18-6 | 4-Bromo-5-fluoro-2-hydrazinylbenzoic acid hydrochloride | Csub7/subHsub6/subBrFNsub2/subOsub2/sub.HCl |
| 1643330-62-4 | 5-Chloro-N-[4-[5,6-dihydro-3-(4-morpholinyl)-2-oxo-1(2H)-pyridinyl]phenyl]pentanamide | Csub20/subHsub26/subClNsub3/subOsub3/sub |
| 1643377-48-3 | 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-N-(3-amino-3-oxopropyl)-1-methyl-N-2-pyridinyl-1H-benzimidazole-5-carboxamide | Csub25/subHsub26/subNsub8/subOsub2/sub |
| 1643378-47-5 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(4-Fluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | Csub23/subHsub29/subFNsub6/subOsub4/subS |
| 1643378-48-6 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(2,3-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | Csub23/subHsub28/subFsub2/subNsub6/subOsub4/subS |
| 1643479-47-3 | 9-[1,1'-Biphenyl]-3-yl-9'-[1,1'-biphenyl]-4-yl-3,3'-bi-9H-carbazole | Csub48/subHsub32/subNsub2/sub |
| 1643526-99-1 | 3-([1,1'-Biphenyl]-3-yl)-9H-carbazole | Csub24/subHsub17/subN |
| 1643678-96-9 | 9-(4-Dibenzofuranyl)-9H-fluoren-9-ol | Csub25/subHsub16/subOsub2/sub |
| 1643684-05-2 | Atomoxetine EP Impurity D | Csub17/subHsub21/subNO .HCl |
| 1643684-06-3 | Atomoxetine EP Impurity C | Csub17/subHsub22/subClNO |
| 1643848-13-8 | 4-(2-Benzoxazolyl)-N-phenylbenzenamine | Csub19/subHsub14/subNsub2/subO |
| 1643913-93-2 | (2E)-3-(6-Amino-3-pyridinyl)-N-[[5-[4-[(4,4-difluoro-1-piperidinyl)carbonyl]phenyl]-7-(4-fluorophenyl)-2-benzofuranyl]methyl]-2-propenamide | Csub35/subHsub29/subFsub3/subNsub4/subOsub3/sub |
| 1644054-07-8 | N-(9,9-dimethyl-9H-fluoren-4-yl)-9,9-dimethyl-9H-fluoren-2-amine | Csub30/subHsub27/subN |
| 1644286-34-9 | Pemetrexed EP impurity B & C mixture (1:1) | Csub40/subHsub40/subNsub10/subOsub13/sub |
| 1644287-27-3 | N-[4-[2-(2-Amino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid | Csub20/subHsub21/subNsub5/subOsub7/sub |
| 1644295-07-7 | 3-[[[[2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]amino]carbonyl]-bicyclo[2.2.1]heptane-2-carboxylic acid | Csub28/subHsub38/subNsub4/subOsub3/subS |
| 1644457-28-2 | (5S)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine | Csub13/subHsub20/subNsub2/sub |
| 1644457-29-3 | [(7S)-Hexahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone | Csub23/subHsub27/subNsub5/subO |
| 1644461-85-7 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylsulfinyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | Csub23/subHsub28/subFsub2/subNsub6/subOsub5/subS |
| 1644466-71-6 | 2-(9,9-Diphenyl-9H-fluoren-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | Csub31/subHsub29/subBOsub2/sub |
| 1644545-52-7 | 6-(6-Chloro-2-pyridinyl)-N2,N4-bis[(1R)-2,2,2-trifluoro-1-methylethyl]-1,3,5-triazine-2,4-diamine | Csub14/subHsub13/subClFsub6/subNsub6/sub |
| 1644548-81-1 | Methyl 6-(trifluoromethyl)pyrazine-2-carboxylate | Csub7/subHsub5/subFsub3/subNsub2/subOsub2/sub |
| 1644667-44-6 | (±)-Benzyl 2-(4-Cyanophenyl)-4-Oxo -3,4-Dihydropyridine-1(2H)-Carboxylate | Csub20/subHsub16/subNsub2/subOsub3/sub |
| 1644667-45-7 | (±)-benzyl 2-(4-cyanophenyl)-4-oxopiperidine-1-carboxylate | Csub20/subHsub18/subNsub2/subOsub3/sub |
| 1644667-47-9 | (±)-rel-(2S,4S)-benzyl 2-(4-cyanophenyl)-4-hydroxypiperidine-1-carboxylate | Csub20/subHsub20/subNsub2/subOsub3/sub |
| 1644667-56-0 | (-)-(2S,4S)-Benzyl 2-(4-Cyanophenyl)-4-Hydroxypiperidine-1-Carboxylate | Csub20/subHsub20/subNsub2/subOsub3/sub |